Cannabinoid Impairment
Cannabinoid Impairment is a neurobehavioral condition characterized by the transient disruption of cognitive, motor, and perceptual functions resulting specifically from the pharmacological effects of cannabinoids, particularly delta-9-tetrahydrocannabinol (THC), on the central nervous system.
473
Publications
34.5K
Citations
1.9K
Authors
618
Institutions
Publications per year
2017–2026
112
Parents
473
Benjamin F. Cravatt, Kristin Demarest, Matthew P. Patricelli et al. · Proceedings of the National Academy of Sciences · 2001 · 1.3K citations · Full text
Medicine, Neuroscience, Pharmacology +13
Michelle Glass, Mike Dragunow, Richard L. M. Faull · Neuroscience · 2000 · 525 citations
1–5 of 473
1.9K
13
h-index
12
h-index
11
h-index
9
h-index
8
h-index
1–5 of 1.9K
618
Columbia University
New York, United States
16 h-index
68 publications
9.4K citations

The University of Sydney
Sydney, Australia
16 h-index
58 publications
6.5K citations
Maastricht University
Maastricht, The Netherlands
14 h-index
50 publications
7K citations

Johns Hopkins University
Baltimore, United States
12 h-index
45 publications
3.4K citations
University of California, Los Angeles
Los Angeles, United States
11 h-index
35 publications
1.6K citations
Inserm
Paris, France
11 h-index
44 publications
2.4K citations

University of Wollongong
Wollongong, Australia
11 h-index
25 publications
1.3K citations
Indiana University Bloomington
Bloomington, United States
11 h-index
29 publications
1.1K citations
1–8 of 618
33 publications · 2.4K citations
27
h-index
22 publications · 3.2K citations
22
h-index
22 publications · 1.8K citations
17
h-index
20 publications · 2.1K citations
16
h-index
Repository · 17 publications · 767 citations
15
h-index
1–5